Works matching DE "TUMOR markers"


Results: 5000
    1

    Trial Watch.

    Published in:
    OncoImmunology, 2014, v. 3, n. 4, p. N.PAG, doi. 10.4161/onci.28185
    By:
    • Pol, Jonathan;
    • Bloy, Norma;
    • Obrist, Florine;
    • Eggermont, Alexander;
    • Galon, Jérôme;
    • Hervé Fridman, Wolf;
    • Cremer, Isabelle;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Galluzzi, Lorenzo
    Publication type:
    Article
    2
    3
    4

    Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR<sup>+</sup> NK cell levels correlate with disease outcome.

    Published in:
    OncoImmunology, 2013, v. 2, n. 2, p. e23080-1, doi. 10.4161/onci.23080
    By:
    • Chaput, Nathalie;
    • Flament, Caroline;
    • Locher, Clara;
    • Desbois, Mélanie;
    • Rey, Annie;
    • Rusakiewicz, Sylvie;
    • Poirier-Colame, Vichnou;
    • Pautier, Patricia;
    • Le Cesne, Axel;
    • Soria, Jean-Charles;
    • Paci, Angelo;
    • Rosenzwajg, Michelle;
    • Klatzmann, David;
    • Eggermont, Alexander;
    • Robert, Caroline;
    • Zitvogel, Laurence
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Tissue elasticity properties as biomarkers for prostate cancer.

    Published in:
    Cancer Biomarkers, 2008, v. 4, n. 4/5, p. 213, doi. 10.3233/CBM-2008-44-505
    By:
    • Hoyt, Kenneth;
    • Castaneda, Benjamin;
    • Zhang, Man;
    • Nigwekar, Priya;
    • di Sant'Agnese, P. Anthony;
    • Joseph, Jean V.;
    • Strang, John;
    • Rubens, Deborah J.;
    • Parker, Kevin J.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal dissemination.

    Published in:
    Gastric Cancer, 2025, v. 28, n. 4, p. 569, doi. 10.1007/s10120-025-01609-7
    By:
    • Angerilli, Valentina;
    • Callegarin, Matilde;
    • Govoni, Ilaria;
    • De Lisi, Giuseppe;
    • Paudice, Michele;
    • Fugazzola, Paola;
    • Vanoli, Alessandro;
    • Parente, Paola;
    • Bergamo, Francesca;
    • Luchini, Claudio;
    • Dei Tos, Angelo Paolo;
    • Grillo, Federica;
    • Lonardi, Sara;
    • Mastracci, Luca;
    • Spolverato, Gaya;
    • Fassan, Matteo
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    42

    Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250
    By:
    • LaPelusa, Michael;
    • Chamseddine, Shadi;
    • Tran Cao, Hop Sanderson;
    • Xiao, Lianchun;
    • Hasanov, Elshad;
    • Bhosale, Priya;
    • Amin, Hesham M.;
    • Mohamed, Yehia I.;
    • Gok Yavuz, Betul;
    • Sakr, Yara;
    • Xu, Li;
    • Hu, Ian;
    • Lee, Sunyoung S.;
    • Sakamuri, Divya;
    • Jindal, Sonali;
    • Nguyen, Van;
    • Curran, Michael A.;
    • Sun, Ryan;
    • Rashid, Asif;
    • Duda, Dan Gabriel
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50